RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Vivus Inc.

A collection of news and information related to Vivus Inc. published by this site and its partners.

Top Vivus Inc. Articles

Displaying items 1-12
  • Vivus' Stendra gets FDA approval for use 15 minutes before sex

    (Reuters) - The erectile dysfunction drug Stendra, currently approved by the U.S. Food and Drug Administration for use 30 minutes before sex, has now been approved for use as little as 15 minutes before sex, the drug's developers said on Thursday....
  • S&P 500 toca récord tras comunicado de la Fed, liderado por sector financiero

    NUEVA YORK (Reuters) - Las acciones subían el jueves en la bolsa de Nueva York, con el índice S&P 500 tocando un máximo histórico un día después de que la Reserva Federal renovó su compromiso de mantener bajas las tasas de interés. * La Fed dijo el...
  • U.S. FDA panel: Novo Nordisk's liraglutide safe, effective for obesity

    WASHINGTON (Reuters) - Novo Nordisk's drug liraglutide is safe and effective enough to warrant approval for use in chronically obese patients with at least one weight-related health issue, an advisory panel to the U.S. Food and Drug Administration...
  • Long-awaited diet pill gets U.S. approval

    Long-awaited diet pill gets U.S. approval
    (Reuters) - A new diet pill Contrave got approval to be sold in the United States on Wednesday, only the third obesity treatment in more than a decade to win approval from the Food and Drug Administration. Made by Orexigen Therapeutics Inc, Contrave is a...
  • Diet drug Qnexa: Don't get too carried away by new study

    The diet drug Qnexa helps obese people with weight-related medical conditions to lose more weight than those who take a dummy pill and could allow some to scale back on medications for diabetes, high blood pressure or cholesterol, according to a new study...
  • Obesity drugs need heart studies, U.S. advisers say

    Obesity drugs need heart studies, U.S. advisers say
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...
  • FDA shoots down another weight loss drug [Updated]

    FDA shoots down another weight loss drug [Updated]
    The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of  the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...
  • Teaming up to save your skin

    Products by two Hampton Roads organizations are on the cutting edge of wound care. The nonprofit LifeNet Health in Virginia Beach offers TheraSkin, a graft made of real skin that stimulates your body to heal itself. Soluble Systems of Newport News...
  • FDA approves new diet drug

    FDA approves new diet drug
    The Food and Drug Administration approved a new prescription diet drug called Qsymia on Tuesday. The medication produced dramatic weight loss in clinical trials, but some are concerned over potential side effects, including increased heart rate, birth...
  • Nuevo rival para el Viagra

    Nuevo rival para el Viagra
    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...
  • Orgasm Inc. -- The Hunt for the Female Viagra

    Orgasm Inc. -- The Hunt for the Female Viagra
    LOS ANGELES -- It's a condition called 'Female Sexual Dysfunction," or 'FSD,' supposedly afflicting women who are dissatisfied with their sex lives. It's been widely reported to affect 43 percent of all women -- but it is real? Documentary filmmaker...
  • Diet drugs face tough test

    Diet drugs face tough test
    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...